Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | POLE |
| Variant | P286R |
| Impact List | missense |
| Protein Effect | loss of function |
| Gene Variant Descriptions | POLE P286R lies within the exonuclease domain of the Pole protein (PMID: 29352080). P286R is associated with hypermutation in patient samples (PMID: 27612425, PMID: 23528559), results in a perturbation of the DNA-binding pocket by structural modeling (PMID: 23528559), and confers impaired exonuclease activity and increased mutation rate compared to wild-type Pole in vitro (PMID: 25228659, PMID: 29352080). |
| Associated Drug Resistance | |
| Category Variants Paths |
POLE mutant POLE inact mut POLE P286R |
| Transcript | NM_006231.4 |
| gDNA | chr12:g.132676598G>C |
| cDNA | c.857C>G |
| Protein | p.P286R |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| XM_011534795 | chr12:g.132676598G>C | c.857C>G | p.P286R | RefSeq | GRCh38/hg38 |
| XM_011534795.4 | chr12:g.132676598G>C | c.857C>G | p.P286R | RefSeq | GRCh38/hg38 |
| XM_011534800 | chr12:g.132676598G>C | c.857C>G | p.P286R | RefSeq | GRCh38/hg38 |
| NM_006231 | chr12:g.132676598G>C | c.857C>G | p.P286R | RefSeq | GRCh38/hg38 |
| XM_047429018.1 | chr12:g.132676598G>C | c.857C>G | p.P286R | RefSeq | GRCh38/hg38 |
| XM_011534795.3 | chr12:g.132676598G>C | c.857C>G | p.P286R | RefSeq | GRCh38/hg38 |
| XM_011534799.3 | chr12:g.132676598G>C | c.857C>G | p.P286R | RefSeq | GRCh38/hg38 |
| NM_006231.4 | chr12:g.132676598G>C | c.857C>G | p.P286R | RefSeq | GRCh38/hg38 |
| XM_011534799 | chr12:g.132676598G>C | c.857C>G | p.P286R | RefSeq | GRCh38/hg38 |
| NM_006231.3 | chr12:g.132676598G>C | c.857C>G | p.P286R | RefSeq | GRCh38/hg38 |
| XM_011534799.2 | chr12:g.132676598G>C | c.857C>G | p.P286R | RefSeq | GRCh38/hg38 |
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|